Disease progression and defects in primary hemostasis as major cause of bleeding in multiple myeloma.
Clemens HinterleitnerAnn-Christin PecherKlaus-Peter KreißelmeierUlrich BuddeLothar KanzHans-Georg KoppKarl JaschonekPublished in: European journal of haematology (2019)
Bleeding complications in MM are predominantly caused by defects in primary hemostasis and associated with disease progression. In a peri-interventional workup, determination of CTs and VWF:CB/VWF:Ag ratios are of significant importance to assess bleeding risk.